Novartis next generation CAR-T cell therapy CTL119 combined with … – GlobeNewswire (press release)
|
Novartis next generation CAR-T cell therapy CTL119 combined with …
GlobeNewswire (press release) Eight of nine evaluable patients tested had no signs of CLL in their bone marrow at three months. CTL119 is a humanized CD19-directed CAR-T cell therapy … |
